The week in industry: Breakthrough therapy status for chronic lymphocytic leukemia treatment
This week: Virtual Research and Development Center announced to advance cancer therapies, Jazz Pharmaceuticals (Dublin, Ireland) acquires Cavion (VA, USA) for US$312.5 million and US court rules in favor of Amgen (CA, USA) in patnet case.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>